All News

After any kind of health trauma, even the good news comes with an air of skepticism, caution and even fear. That said, there's a reason to celebrate any day we get to live and argue in favor of faith and hope, not fear.

Vertical motion helps stimulate the lymphatic system aiding in the disbursement of lymphatic fluid.

Morris Sherman discusses finding second-line treatments for patients with HCC.

The incidence of NASH-associated liver cancer is growing, prompting researchers to further investigate this subset of patients.

CURE spoke with Ghassan K. Abou-Alfa about the potential of using a vaccinia to treat advanced HCC.

Since being diagnosed with thymic cancer late in 2009, I have written articles, a book and blogged about the cancer experience mostly as a therapeutic exercise — a way to cast the demon outside of myself — and as an offering to others survivors.

There are now more personalized treatment options for patients with CLL.

Neoadjuvant chemotherapy is the best option for some patients with ovarian cancer, according to a recent report.

Those acting as caregivers to patients with cancer often face their own set of hardships.

In honor of Ovarian Cancer Month, it is only appropriate for me to discuss ovarian cancer. "Ovarian cancer" are two of the scariest words in any language for a woman to hear — screening for it at this time is poor and more often than not, by the time it is detected it is too late.

Any diagnosis of cancer is frightening, but the functional, psychological and cosmetic effects of oral cancer treatment create an additional layer of fear. Even patients who are treated successfully will require care throughout their lives. This disease exacts an unending physical and mental price.

CURE spoke with Yvonee Saenger about the future use of Opdivo and Yervoy in melanoma.

The FDA granted Keytruda a priority review for the first-line treatment of some patients with NSCLC.

What does it feel like when a friend with metastatic cancer learns that cancer has spread again?

Breast cancer and melanoma survivor works on resilience to cope with her two cancers.

A recent study showed that patients with MPNs treated with Jakafi off a clinical trial still benefited from the drug.

The chemotherapy agent capecitabine causes some patients to lose their fingerprints.

After multiple bouts with cancer, Taylor Hendrix was inspired to become an oncology nurse.

This male breast cancer survivor spent a year in residence in a Zen Buddhist Temple. Then he got cancer. Here’s what he learned.

When a cancer diagnosis requires a lifestyle overhaul, it's important to recognize the gifts this forced transition brings.

A recent review showed that music therapy helped ease symptoms in patients who were undergoing treatment for cancer.

A three-drug approach is proving beneficial for the treatment of multiple myeloma.

Several factors cause women a delay in getting surgery to treat endometrial cancer.

On starting a new chapter, but never forgetting.

I’m not sure that’s the right term. Do I have a choice?

According to recent findings from a phase 3 trial, the immunotherapy Tecentriq (atezolizumab) improved survival compared with docetaxel in patients with advanced non–small cell lung cancer (NSCLC) following the failure of platinum-based chemotherapy.